Metaphylaxis in patients with gout, complicated by urolithiasis and nephropathy
- 作者: Avdoshyn V.P1, Andryukhin M.I1, Annenkov A.V1, Pulbere S.A1, Chugayev V.V1
-
隶属关系:
- 期: 编号 2 (2013)
- 页面: 30-33
- 栏目: Articles
- URL: https://journals.eco-vector.com/2075-3594/article/view/261733
- ID: 261733
如何引用文章
开放存取
##reader.subscriptionAccessGranted##
详细
Aim. Estimation of clinical efficacy of metaphylaxis in patients with gout, urate nephrolithiasis and nephropathy. Methods. 112 (79 men, 33 women, mean age 57+7 years) with gout, urate nephrolithiasis and nephropathy were included into the study. All of them were treated with Trometamol n (500 ml intravenously, course of 10 infusions). Duration of gout varied from 2 to 27 years (mean і0,2 years). Results. Use of Trometamol N was associated with decrease of uricemia, creatininemia and increase of urinary uric acid excretion. Gout arthritis attack was seen in only 1 (0,9%) of patients. Trometamol N was well tolerated. Conclusion. Trometamol N can be used for uricemia control in patients with gout and uric acid nephropathy.
全文:
参考
- Барскова В.Г., Авдошин В.П. Подагра и уратный нефролитиаз. М., 2012. 36 с.
- Борисов В.В., Шилов Е.М. Фитотерапия нефролитиаза. Саратовский научно-медицинский журнал. 2011;7(2):23—30.
- Лопаткин Г.А., Яненко Э.К. Мочекаменная болезнь. В кн.: Нефрология / Под ред. И.Е. Тареевой. М., 1995;2:331-355.
- Мухин Н.А., Балкаров И.М. Подагрическая почка. В кн.: Нефрология/Под ред. И.Е. Тареевой. М., 1995;2:321-330.
- Николаев А.Ю., Милованов Ю.С. Нарушения пуринового обмена и подагрическая нефропатия. Лечащий врач. 2006;10:54-57.
- Насонова В.А. Диагностика и лечение подагры// Тер. архив. 1987;4:3-7.
- Пытель Ю.А., Золотарев И.И. Уратный нефролитиаз. М., 1995. 182 с.
- Тиле П. Эпидемиология и патогенез нарушений пуринового обмена / П. Тиле Х.Е. Шредер. // Тер. архив. 1987;4:14-18.
- Rose B.D., Becker M.A. Uric Acid Nephrolithiasis. UpToDate. 2003.12.1.
- Vecchio P.C., Emmerson B.T. Gout due to renal disease. Br. J. Rheumat. 1992;31(1):87-89.
补充文件
